INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt

Stock Information for INmune Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About INmune Bio Inc.

OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer's Trial with Vivo, a Novel genAI Clinical Trial Control Tower
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease
INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro(TM) Promotes Remyelination
INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024
INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.